论文部分内容阅读
目的探讨维拉帕米在经桡动脉心脏介入治疗中的应用及安全性。方法 60例经桡动脉心脏介入治疗的患者,从桡动脉局部注入维拉帕米5mg,观察注入前、后心率、血压、局部和全身的变化及术中是否出现桡动脉痉挛。结果 60例患者注药前后心率、收缩压、舒张压均有一定程度变化,但无统计学意义(P>0.05),术中未出现桡动脉痉挛,无心衰和新的房室传导阻滞出现。结论在经桡动脉心脏介入治疗时,局部注入维拉帕米5mg,可预防桡动脉痉挛,且无明显不良反应,安全有效。
Objective To investigate the application and safety of verapamil in transradial heart intervention. Methods Sixty patients with transradial heart intervention were treated with local injection of verapamil 5 mg from the radial artery. Changes of heart rate, blood pressure, local and systemic changes before and after injection, and whether radial artery spasm occurred during operation were observed. Results The heart rate, systolic blood pressure and diastolic blood pressure of 60 patients before and after injection had some degree of change, but no statistical significance (P> 0.05), no radial artery spasm, no heart failure and new atrioventricular block appear. Conclusion In the transradial heart intervention, local injection of verapamil 5mg can prevent radial artery spasm, and no obvious adverse reactions, safe and effective.